Logo image of ALESA.PA

ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

EPA:ALESA - Euronext Paris - Matif - FR0011490648 - Common Stock - Currency: EUR

0.954  +0.12 (+14.94%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALESA. ALESA was compared to 42 industry peers in the Commercial Services & Supplies industry. While ALESA seems to be doing ok healthwise, there are quite some concerns on its profitability. ALESA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALESA had negative earnings in the past year.
In the past year ALESA has reported a negative cash flow from operations.
ALESA had negative earnings in each of the past 5 years.
In the past 5 years ALESA reported 4 times negative operating cash flow.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

ALESA has a Return On Assets of -11.00%. This is amonst the worse of the industry: ALESA underperforms 80.95% of its industry peers.
ALESA's Return On Equity of -40.65% is on the low side compared to the rest of the industry. ALESA is outperformed by 83.33% of its industry peers.
ALESA has a Return On Invested Capital of 4.01%. This is comparable to the rest of the industry: ALESA outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -11%
ROE -40.65%
ROIC 4.01%
ROA(3y)-10.7%
ROA(5y)-9.36%
ROE(3y)-37.88%
ROE(5y)-30.98%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

ALESA has a better Operating Margin (12.20%) than 85.71% of its industry peers.
Looking at the Gross Margin, with a value of 66.24%, ALESA is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
In the last couple of years the Gross Margin of ALESA has grown nicely.
Industry RankSector Rank
OM 12.2%
PM (TTM) N/A
GM 66.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y14.36%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for ALESA remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALESA has been increased compared to 5 years ago.
ALESA has about the same debt/assets ratio as last year.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -0.77, we must say that ALESA is in the distress zone and has some risk of bankruptcy.
ALESA has a Altman-Z score of -0.77. This is amonst the worse of the industry: ALESA underperforms 80.95% of its industry peers.
A Debt/Equity ratio of 2.05 is on the high side and indicates that ALESA has dependencies on debt financing.
With a Debt to Equity ratio value of 2.05, ALESA is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACCN/A
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALESA has a Current Ratio of 2.66. This indicates that ALESA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.66, ALESA belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
A Quick Ratio of 2.32 indicates that ALESA has no problem at all paying its short term obligations.
ALESA has a Quick ratio of 2.32. This is amongst the best in the industry. ALESA outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.32
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.04% over the past year.
ALESA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.36%.
Measured over the past years, ALESA shows a small growth in Revenue. The Revenue has been growing by 6.62% on average per year.
EPS 1Y (TTM)45.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.15%
Revenue 1Y (TTM)-30.36%
Revenue growth 3Y21.29%
Revenue growth 5Y6.62%
Sales Q2Q%11.45%

3.2 Future

ALESA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.96% yearly.
Based on estimates for the next years, ALESA will show a very strong growth in Revenue. The Revenue will grow by 59.18% on average per year.
EPS Next Y55.5%
EPS Next 2Y57.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year60.53%
Revenue Next 2Y59.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALESA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 1.87, which indicates a rather cheap valuation of ALESA.
ALESA's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALESA is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALESA to the average of the S&P500 Index (22.19), we can say ALESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.87
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALESA's earnings are expected to grow with 57.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALESA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECOSLOPS

EPA:ALESA (6/17/2025, 7:00:00 PM)

0.954

+0.12 (+14.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-17 2025-07-17
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.95M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.87
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)0.51
Fwd EY53.44%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS2.1
BVpS1.54
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11%
ROE -40.65%
ROCE 5.51%
ROIC 4.01%
ROICexc 5.9%
ROICexgc 6.42%
OM 12.2%
PM (TTM) N/A
GM 66.24%
FCFM N/A
ROA(3y)-10.7%
ROA(5y)-9.36%
ROE(3y)-37.88%
ROE(5y)-30.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y14.36%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 4.54%
Interest Coverage 0.75
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.32
Altman-Z -0.77
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.15%
EPS Next Y55.5%
EPS Next 2Y57.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.36%
Revenue growth 3Y21.29%
Revenue growth 5Y6.62%
Sales Q2Q%11.45%
Revenue Next Year60.53%
Revenue Next 2Y59.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y133.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year440%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-542.94%
OCF growth 3YN/A
OCF growth 5YN/A